Balance Sheet Data

GlaxoSmithKline plc (GSK)

$ 41.12
-0.24 (-0.58%)

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 4,9863,9113,9584,7866,1705,449.975,734.436,033.746,348.686,680.05
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories 5,1025,5575,4765,9475,9966,434.726,770.587,123.987,495.827,887.07
Inventories (%)
Accounts Payable 3,5963,5283,6454,1444,3574,410.404,640.604,882.825,137.685,405.84
Accounts Payable (%)
Capital Expenditure -2,352-2,202-1,796-2,163-2,239-2,477.77-2,607.10-2,743.18-2,886.36-3,037.01
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.